The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

The shingles vaccine could do double duty as a protector against both infections and dementia, according to a new study.

Strong immune resilience between 40–70 cuts early death risk by 69%, preserves brain health, and boosts vaccine responses.